Colossal Biosciences claims it has revived an extinct species, but scientists outside the company are skeptical.

CHINO HILLS, CA / ACCESS Newswire / April 7, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is proud to announce th ...

New precision genome editing technologies are transforming the therapeutic landscape for patients with certain cancers and ...

Genome BC announced that it has helped secure more than $49 million for research to be conducted in British Columbia by five projects using genomics to advance personalized healthcare. Three of these ...

The Trump administration's proposal to cut National Institutes of Health (NIH) indirect funds has been widely attacked, with ...

The BRAIN Initiative — the full name is Brain Research Through Advancing Innovative Neurotechnologies — has been talked about ...

The evolution of genomic medicine is driving personalized healthcare, integrating AI and sequencing technologies for improved ...

A precision medicine workflow integrating proteomics and personalized xenograft models was developed and applied to an ...

Protecting animals against environmental changes, poachers, and other dangers is vital yet challenging work. And in recent ...

Liver TET1 was found to promote metabolic dysfunction-associated steatotic liver disease (MASLD) by regulating CD36 ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...